SYNTEX' NAPROSYN/ANAPROX COMBINED SALES IN U.S. APPROACH $90 MIL. IN SECOND QUARTER OF FY 1986; FIRST HALF NAPROXEN SALES TOP $250 MIL. WORLDWIDE

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".